OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
- Sponsor
- Chonnam National University Hospital
- Study ID
- NCT06227754
- Status
- Recruiting
Conditions
- Myocardial Infarction
- ST Elevation Myocardial Infarction
Eligibility Criteria
- Sex
- ALL
- Age
- 19 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Angiography-guided PCI group — PROCEDUREThe PCI procedure in this group will be performed as standard procedure. After deployment of stent, stent optimization will be done based on angiographic findings. The optimization guided by angiography should meet the criteria of angiographic residual diameter stenosis less than 10% by visual estimation and the absence of flow limiting dissection (≥Type C dissection). When angiographic under-expansion of the stent is suspected, adjunctive balloon dilatation will be strongly recommended.
- Optical coherence tomography-guided PCI group — PROCEDURE\[Stent Optimization\] 1. Stent Expansion: Visually assess residual angiographic diameter stenosis \<10% "AND" ① In non-LM lesions: In-stent minimal lumen area (MSA) \>80% of the average reference lumen area "OR" \>4.5 mm2 ② In LM lesion: MSA\>7 mm2 for distal LM and \>8 mm2 for proximal LM 2. Stent Apposition: No major malapposition (defined as a distance from stent strut to adjacent intima ≥400 um and \< 1mm length) of the stent over its entire length against the vessel wall 3. Edge Dissection: No major edge dissection in the proximal or distal reference segments, defined as 5 mm from the edge of the stent, extended to media layer with potential to provoke flow disturbances (defined as \>60° of the circumference of the vessel at site of dissection and/or \>2 mm in length of dissection flap)
Study Details
The aim of the study is to compare clinical outcomes between optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).
Key Dates
- First listed
- Jan 29, 2024
- Start date
- Mar 25, 2024
- Status verified
- May 2026
- Primary completion
- Mar 31, 2031
- Completion
- Dec 31, 2031
Study Design
- Enrollment
- 1,500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Angiography-guided PCIThe PCI procedure in this group will be performed as standard procedure.
- Experimental: Optical coherence tomography-guided PCIUse of OCT will be allowed at any step of PCI (pre-PCI, during PCI and post-PCI), but OCT after stent implantation will be mandatory. In this group, the recommendations for selecting reference segment, selecting appropriate size of stent, and stent optimization are as follows. OPTIS imaging catheter (Abbott Vascular) will be used for the imaging arm according to MLD MAX algorithm.
Primary Outcome Measure
Target vessel failure [ Time Frame: 2 years after last patient enrollment ]
Central Contacts
- Seung Hun Lee, MD, PhD82-2-220-6246
- Young Joon Hong, MD, PhD82-2-220-5778
Related Studies
- Circulating Markers for Ischemic Heart DiseaseRecruiting · UConn Health · Farmington, Connecticut
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Dallas, Texas
- Diffusion MRI in Heart FailureEARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Charlestown, Massachusetts
- Heart Attack Research Program: Platelet Sub-Study (HARP)Recruiting · NYU Langone Health · New York, New York